重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2013年
24期
2869-2870,2872
,共3页
张建明%朱锋%牟华明%庞小华%杨建军%吴中杰%米庆
張建明%硃鋒%牟華明%龐小華%楊建軍%吳中傑%米慶
장건명%주봉%모화명%방소화%양건군%오중걸%미경
尼可地尔%冠状动脉造影%冠状动脉慢血流现象
尼可地爾%冠狀動脈造影%冠狀動脈慢血流現象
니가지이%관상동맥조영%관상동맥만혈류현상
nicorandil%coronary angiography%coronary slow flow phenomenon
目的评价应用尼可地尔治疗冠状动脉慢血流现象(CSFP)的疗效及安全性。方法选择CSFP患者60例,按照随机、单盲和安慰剂对照的方法分为治疗组30例与对照组30例;观察治疗前、后两组临床症状的改善、胸痛发作频率与持续时间变化、6 min步行实验的改变和校正的血流分级(TIMI)血流计数及下降程度的变化,以及治疗前、后血常规及肝肾功能指标变化。结果尼可地尔治疗组改善临床症状有效率优于对照组(P<0.01);尼可地尔治疗后,胸痛发作频率和持续时间较前减少(P<0.01,P<0.05),6 min步行实验距离较前显著增加(P<0.01),校正的TIMI血流计数较前显著降低(P<0.01),且均优于对照组(P<0.01);患者血常规及肝肾功能检查治疗前、后均在正常范围(P>0.05)。结论尼可地尔治疗CSFP有较好的疗效且应用安全。
目的評價應用尼可地爾治療冠狀動脈慢血流現象(CSFP)的療效及安全性。方法選擇CSFP患者60例,按照隨機、單盲和安慰劑對照的方法分為治療組30例與對照組30例;觀察治療前、後兩組臨床癥狀的改善、胸痛髮作頻率與持續時間變化、6 min步行實驗的改變和校正的血流分級(TIMI)血流計數及下降程度的變化,以及治療前、後血常規及肝腎功能指標變化。結果尼可地爾治療組改善臨床癥狀有效率優于對照組(P<0.01);尼可地爾治療後,胸痛髮作頻率和持續時間較前減少(P<0.01,P<0.05),6 min步行實驗距離較前顯著增加(P<0.01),校正的TIMI血流計數較前顯著降低(P<0.01),且均優于對照組(P<0.01);患者血常規及肝腎功能檢查治療前、後均在正常範圍(P>0.05)。結論尼可地爾治療CSFP有較好的療效且應用安全。
목적평개응용니가지이치료관상동맥만혈류현상(CSFP)적료효급안전성。방법선택CSFP환자60례,안조수궤、단맹화안위제대조적방법분위치료조30례여대조조30례;관찰치료전、후량조림상증상적개선、흉통발작빈솔여지속시간변화、6 min보행실험적개변화교정적혈류분급(TIMI)혈류계수급하강정도적변화,이급치료전、후혈상규급간신공능지표변화。결과니가지이치료조개선림상증상유효솔우우대조조(P<0.01);니가지이치료후,흉통발작빈솔화지속시간교전감소(P<0.01,P<0.05),6 min보행실험거리교전현저증가(P<0.01),교정적TIMI혈류계수교전현저강저(P<0.01),차균우우대조조(P<0.01);환자혈상규급간신공능검사치료전、후균재정상범위(P>0.05)。결론니가지이치료CSFP유교호적료효차응용안전。
Objective To evaluate the effect and safety of nicorandil on Coronary Slow Flow Phenomenon (CSFP) .Methods The CSFP patients(n=60) were randomly divided into the control group treated with placebo and the treatment group treated with nicorandil .The changes of the clinical symptoms ,the frequency and duration of pectoralgia ,the six-minute walk test ,and TIMI frame counts were observed before and after treatment .Results The treatment group had a better therapeutic effect than the con-trol group(P<0 .05) .There were significant differences in the frequency and duration of pectoralgia ,the six-minute walk test ,and TIMI frame counts in treatment group before and after treatment ,which were superior to those of control group (P<0 .05 ,P<0 .01) .The blood routine examinations and hepatorenal function were within the normal range before and after treatment .Conclusion Nicorandil has better therapeutic effect and safety on CSFP .